LIVE NEWS
  • Ledger, BBC Among 178 Organizations Hit by Crypto Malware
  • US basketball player arrested in Nigeria over 75 pounds of cannabis
  • CMS proposes more aggressive audits of Medicare Advantage| STAT
  • Microsoft says months-old bug caused global Microsoft 365 outage
  • James Bond live updates: Robert Pattinson named as new 007
  • Wildfire Lawsuits Against Utilities Fuel a Debate Over Who Should Pay
  • Tiny robots can tumble through blood vessels to help dissolve blood clots, early test shows
  • The Verge’s guide to the best gifts under $100
Prime Reports
  • Home
  • Popular Now
  • Crypto
  • Cybersecurity
  • Economy
  • Geopolitics
  • Global Markets
  • Politics
  • See More
    • Artificial Intelligence
    • Climate Risks
    • Defense
    • Healthcare Innovation
    • Science
    • Technology
    • World
Prime Reports
  • Home
  • Popular Now
  • Crypto
  • Cybersecurity
  • Economy
  • Geopolitics
  • Global Markets
  • Politics
  • Artificial Intelligence
  • Climate Risks
  • Defense
  • Healthcare Innovation
  • Science
  • Technology
  • World
Home»Healthcare Innovation»Missouri AG pushes back on Lilly’s 340B data demands| STAT
Healthcare Innovation

Missouri AG pushes back on Lilly’s 340B data demands| STAT

primereportsBy primereportsOctober 28, 2026No Comments2 Mins Read
Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
Missouri AG pushes back on Lilly’s 340B data demands| STAT
Share
Facebook Twitter LinkedIn Pinterest Email


Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter and the afternoon Pharmalot newsletter.

Missouri Attorney General Catherine Hanaway (R) has warned Eli Lilly to discontinue its practice of requiring hospitals to provide claims data to receive discounted medicines under a federal program, a sign that more states are pushing back against such moves by drugmakers.

In an Oct. 26 cease-and-desist letter sent to the company, Hanaway maintained that Lilly has “broken” its promise to sell its medicines under the 340B Drug Pricing Program to eligible hospitals in the state. As a result, she contended the drugmaker has made “false and misleading statements” and violated state law.

STAT Plus: Hospitals sue – again – to halt Trump administration’s 340B rebate pilot

Hanaway pointed to University of Missouri Health Care, which operates seven hospitals in the state and, she maintained, recently agreed to provide claims data. Yet Hanaway said Lilly denied the health care system discounts on its medicines anyway, and asked the drugmaker to end its new policy by Nov. 26.

STAT+ Exclusive Story

Already have an account? Log in

‘Two-sided risk’ Medicare Advantage plans improve patient outcomes



STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Previous ArticleVanEck launches diversified ETF combining stocks, bonds and Bitcoin exposure
Next Article Apple Creator Studio is getting even better, with new AI tools and a big Final Cut Pro upgrade
primereports
  • Website

Related Posts

Healthcare Innovation

CMS proposes more aggressive audits of Medicare Advantage| STAT

November 17, 2026
Healthcare Innovation

New company Tom Health aims to fix primary care with AI tool| STAT

November 16, 2026
Healthcare Innovation

HHS, Eli Lilly, Oura, basal ganglia: Readout Newsletter

November 16, 2026
Add A Comment
Leave A Reply Cancel Reply

Top Posts

Threat of further violence looms after Mexican cartel rampage

February 25, 2026116 Views

‘Two-sided risk’ Medicare Advantage plans improve patient outcomes

February 24, 202673 Views

Police chief urges those ‘who know nothing about Northern Ireland’ not to stir up disorder via social media – UK politics live | Politics

June 9, 202631 Views
Stay In Touch
  • Facebook
  • YouTube
  • TikTok
  • WhatsApp
  • Twitter
  • Instagram
Latest Reviews

Subscribe to Updates

Get the latest tech news from FooBar about tech, design and biz.

PrimeReports.org
Independent global news, analysis & insights.

PrimeReports.org brings you in-depth coverage of geopolitics, markets, technology and risk – with context that helps you understand what really matters.

Editorially independent · Opinions are those of the authors and not investment advice.
Facebook X (Twitter) LinkedIn YouTube
Key Sections
  • World
  • Crypto
  • Cybersecurity
  • Geopolitics
  • Global Markets
  • Artificial Intelligence
All Categories
  • Artificial Intelligence
  • Climate Risks
  • Crypto
  • Cybersecurity
  • Defense
  • Economy
  • Geopolitics
  • Global Markets
  • Healthcare Innovation
  • Politics
  • Popular Now
  • Science
  • Technology
  • World
  • About Us
  • Contact Us
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Cookie Policy
  • DMCA / Copyright Notice
  • Editorial Policy

Sign up for Prime Reports Briefing – essential stories and analysis in your inbox.

By subscribing you agree to our Privacy Policy. You can opt out anytime.
Latest Stories
  • Ledger, BBC Among 178 Organizations Hit by Crypto Malware
  • US basketball player arrested in Nigeria over 75 pounds of cannabis
  • CMS proposes more aggressive audits of Medicare Advantage| STAT
© 2026 PrimeReports.org. All rights reserved.
Privacy Terms Contact

Type above and press Enter to search. Press Esc to cancel.